1. Introduction {#sec1-molecules-23-01324}
===============

Sphingolipids (SPLs) represent the largest class of bioactive lipids involved in many aspects of cell structure, metabolism, and regulation \[[@B1-molecules-23-01324]\]. Dysregulation of SPL homeostasis has been implicated in various diseases, including inflammation, cancer, obesity, and neurodegenerative disorders \[[@B2-molecules-23-01324],[@B3-molecules-23-01324],[@B4-molecules-23-01324],[@B5-molecules-23-01324]\]. All SPLs share the common backbones of sphingoid bases, a set of aliphatic amino alcohols that contains sphingosine (So) and sphinganine (Sa) ([Figure 1](#molecules-23-01324-f001){ref-type="fig"}). As the simplest type, sphingoid bases can be amide-linked with a fatty acid to convert into ceramide (Cer). These basic SPLs can be further derivatized to: (i) phosphates, e.g., sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P); (ii) phosphosphingolipids, e.g., sphingomyelin (SM); and (iii) glycosphingolipids, e.g., glucosylceramide (GlcCer) and lactosylceramide (LacCer). The structural diversity and complexity of SPLs, due to the numerous variations in sphingoid backbones, fatty acid chains, and head groups, brings significant analytical challenges for their study. Therefore, the introduction of "sphingolipidomics" aims for comprehensive analysis of all SPLs present in a biological system, and is urgently required to understand the roles of SPLs in biology and disease \[[@B1-molecules-23-01324]\].

Nowadays, liquid chromatography-mass spectrometry (LC-MS) has become the most powerful technique for sphingolipidomic analysis owing to its high sensitivity, specificity, and throughput capabilities \[[@B6-molecules-23-01324]\]. Nevertheless, because of the extreme complexity of SPLs, there are still several difficulties in current LC-MS methods using triple-quadrupole mass spectrometry (QQQ-MS) in multiple reaction monitoring (MRM) mode \[[@B6-molecules-23-01324],[@B7-molecules-23-01324]\]. A key limitation is that the existing methods for SPL profiling often suffer from isomeric, isobaric, or isotopic interferences, leading to a failure in detection of the low-abundance but biologically important SPLs. To solve this problem, the latest methodology developed by our group is mainly based on ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) \[[@B8-molecules-23-01324]\]. UPLC provides sufficient separation of the interfering species. High resolution Q-TOF-MS offers accurate mass measurements at both MS and MS/MS level, permitting a reliable identification for subsequent quantification. This strategy appears promising for sphingolipidomic studies, including the discovery of disease biomarkers, as well as the evaluation of therapeutic effects of drug \[[@B8-molecules-23-01324],[@B9-molecules-23-01324]\].

Rheumatoid arthritis (RA) is a chronic, destructive, and autoimmune disease characterized by inflammation in movable joints \[[@B10-molecules-23-01324]\]. Growing evidence shows the significant role of SPLs in the pathogenesis of RA, and also demonstrates their potential as therapeutic targets for RA treatment \[[@B10-molecules-23-01324],[@B11-molecules-23-01324]\]. However, until now, there has been no sphingolipidomic study focusing on this area. Herein, we firstly report an UPLC-Q-TOF-MS-based sphingolipidomic approach for the comprehensive identification and quantification of SPLs in rat serum. The developed method was fully validated and applied to RA study. Serum samples collected from rats in control, model, and indomethacin (IDM)-treated groups were comparatively analyzed. Partial least squares-discriminant analysis (PLS-DA) was further employed to identify the arthritis-related lipid alterations and explore the anti-arthritic mechanism of IDM.

2. Results and Discussion {#sec2-molecules-23-01324}
=========================

2.1. Comprehensive Identification of SPLs in Rat Serum {#sec2dot1-molecules-23-01324}
------------------------------------------------------

UPLC-Q-TOF-MS is a useful analytical tool to separate and identify SPLs in complex matrices. The targeted-MS/MS analysis offered by Q-TOF-MS provides the accurate mass of both molecular and fragment ions, which are informative for SPL identification. Taking *m*/*z* 300.2897 (So), 596.5967 (Cer), 862.6245 (LacCer), and 799.6679 (SM) as examples, the fragmentation patterns of each species were summarized, as shown in [Figure 2](#molecules-23-01324-f002){ref-type="fig"}. The neutral loss of H~2~O and/or HCHO observed from MS/MS spectra corresponds to the hydroxyl group in sphingoid backbone. The characteristic ions specific to sphingoid backbone are decisive for the structural elucidation of SPLs, e.g., *m*/*z* 266.2834, 264.2679, and 262.2526 ions for the assignment of d18:0, d18:1, and d18:2 backbones, respectively \[[@B6-molecules-23-01324],[@B8-molecules-23-01324]\]. Additionally, the abundant phosphocholine ion at *m*/*z* 184.0726 is regarded as the diagnostic fragment for the confirmation of SMs \[[@B6-molecules-23-01324]\]. For complex glycosphingolipids, the neutral loss of sugar units reflects their sugar residue compositions, e.g., two 162 u gaps from the ions of *m*/*z* 862.6245 to 538.5173 suggesting the sequential loss of two glucosyl groups. Based on these fragmentation rules mentioned above, a total of 120 SPLs were identified in rat serum samples, covering seven subcategories (i.e., So and Sa, S1P, Cer, C1P, hexosylceramide (HexCer), LacCer, and SM) with various sphingoid and fatty acid chain compositions ([Table 1](#molecules-23-01324-t001){ref-type="table"} and [Figure S1](#app1-molecules-23-01324){ref-type="app"}). It is worth mentioning that HexCer includes GlcCer and galactosylceramide (GalCer), which cannot be distinguished by this method.

In the current analysis, MS signals might be interfered by isomeric or isobaric ions. A major interference in SPL identification is the isomeric species that have same molecular formula, thus, MS/MS data are necessary for discrimination. For example, the extracted ion chromatogram of *m*/*z* 652.6602 (mass accuracy within 5 ppm) yielded two Cer peaks at 20.3 and 20.9 min, respectively ([Figure 3](#molecules-23-01324-f003){ref-type="fig"}a). Further checking their MS/MS spectra revealed characteristic product ions corresponding to d18:0 (*m*/*z* 266.2839) and d20:0 (*m*/*z* 294.3151) backbones, providing evidence for the differentiation of the two isomers. Another issue is the isobaric interference from sodium adduct ions of SPLs. As seen in [Figure 3](#molecules-23-01324-f003){ref-type="fig"}b, the \[M + H\]^+^ ion of SM (d18:2/24:2) (calculated *m*/*z* 809.6533) coincides exactly with the *m*/*z* for \[M + Na\]^+^ ion of SM (d18:1/22:0) (calculated *m*/*z* 809.6516). In this case, the "real" \[M + H\]^+^ ion could be unambiguously assigned by the observation of its corresponding \[M + Na\]^+^ ion. Compared with other SPLs, identification of SMs is relatively difficult because they are more prone to form sodium adducts. It should be noticed that sufficient chromatographic separation aids in the elimination of isomeric/isobaric interferences and, therefore, facilitates accurate characterization and quantification of these species.

On the basis of optimized separation, linear regression models were constructed by plotting carbon number vs. retention time of SPLs sharing the same sphingoid backbone and unsaturated degree ([Figure S2](#app1-molecules-23-01324){ref-type="app"}) \[[@B7-molecules-23-01324],[@B8-molecules-23-01324]\]. Goodness of fit (*R*^2^ \> 0.998 for each series) implies its capability for predicting retention behavior of the species given its chain composition, as well as for aiding in identification. This is also beneficial for the analysis of other biological samples enriched in SPLs, such as neural cells and tissues.

2.2. Method Validation for Quantitative Profiling {#sec2dot2-molecules-23-01324}
-------------------------------------------------

The established UPLC-Q-TOF-MS method was further validated for SPL quantification \[[@B7-molecules-23-01324]\]. Aliquots of pooled serum from control rats were utilized for the method validation. Linearity was determined by spiking eight internal standards (IS) into samples prior to extraction at a series of spiked levels from 0.0167 to 25 µmol/L. Each sample was prepared in duplicate and measured twice. Calibration curves were constructed by linear regression. A wide dynamic range over three orders of magnitude was achieved for all IS with correlation coefficients (*R*^2^) better than 0.995. Limit of detection (LOD) and limit of quantification (LOQ) were defined as the lowest concentration when signal-to-noise ratio (S/N) of three and 10 were obtained, respectively. As shown in [Table S1](#app1-molecules-23-01324){ref-type="app"}, the LOD and LOQ values of 8 IS ranged from 0.11--2.80 nmol/L and 0.36--9.33 nmol/L, respectively.

Intraday reproducibility was assessed by analyzing six replicates of the serum samples at different times within one day. For interday reproducibility, nine replicates of samples were measured during three consecutive days (each day three samples were prepared and analyzed). Endogenous SPLs belonging to different subcategories were randomly selected and relative standard deviations (RSDs) were used to evaluate the reproducibility. As seen in [Figure S3](#app1-molecules-23-01324){ref-type="app"}, the RSDs of intraday and interday variations for eleven representative SPLs were lower than 4.6% and 8.8%, respectively. Recovery was verified by comparing peak areas of IS spiked into samples before and after SPL extraction at three different levels (5, 50, and 500 pmol). At each spiked level, triplicates of samples were prepared and analyzed. The extraction recoveries of all IS were between 91.3% and 108.5% with RSDs less than 12.5% ([Table S2](#app1-molecules-23-01324){ref-type="app"}). All above results demonstrated that the proposed method was acceptable for routine SPL profiling.

2.3. Application in Study of RA and IDM Intervention in Rats {#sec2dot3-molecules-23-01324}
------------------------------------------------------------

To show the potential of the developed method, sphingolipidomic profiling was applied to rat serum samples obtained from control, model, and IDM-treated groups. A PLS-DA method was then used to visualize the lipid variations among these samples ([Figure 4](#molecules-23-01324-f004){ref-type="fig"}). The score plot showed a clear separation between the control and model groups in the first dimension, indicating a distinct arthritis induced by CFA. After the treatment of IDM, the serum SPL profiles were found to move away from the models and exhibit a tendency to restore to the controls, reflecting a protective effect of IDM against RA. Additionally, alterations of differential SPLs contributing to the classification were also investigated via one-way ANOVA analysis. Twenty-six SPLs were, therefore, selected as potential inflammatory markers, as shown in [Figure 5](#molecules-23-01324-f005){ref-type="fig"}.

In the identified markers, Cers, HexCers, So, Sa, and S1P displayed up-regulation in the arthritic model rats, while SMs were down-regulated. These results suggest that an impaired SPL metabolism is involved in RA ([Figure 6](#molecules-23-01324-f006){ref-type="fig"}). During inflammation, the key cytokine TNF-α can induce the overexpression of cyclooxygenase-2 (COX-2) and promote the release of pro-inflammatory prostaglandin E~2~ (PGE~2~) \[[@B2-molecules-23-01324],[@B12-molecules-23-01324]\]. TNF-α also stimulates specific SPL metabolic enzymes, including ceramidase (CDase) and sphingosine kinase (SphK), to increase the levels of Cers and S1P \[[@B13-molecules-23-01324],[@B14-molecules-23-01324]\]. As the structural core of SPLs, Cer is thought to have crucial roles in the development of inflammation Recent evidence has revealed that Cer accumulation enhances the COX-2 expression and PEG~2~ liberation, giving rise to various inflammatory diseases \[[@B15-molecules-23-01324],[@B16-molecules-23-01324]\]. In addition to Cer, S1P is also able to activate the COX-2 enzyme and trigger the production of PEG~2~ \[[@B14-molecules-23-01324]\]. SphK activation and high S1P levels have been reported in the synovial fluids of patients with RA \[[@B17-molecules-23-01324]\]. Therefore, our findings of significant increment of Cers (together with their metabolites HexCers or So) and S1P in arthritic rats indicate an involvement of TNF-α-mediated inflammation in RA. Furthermore, neutral sphingomyelinase-2 (*n*SMase-2), which hydrolyzes SM into Cer, plays an important role in the inflammatory process. This enzyme has been shown to be activated by TNF-α, resulting in a reduction in SMs and of elevation of Cers observed in this study \[[@B18-molecules-23-01324]\]. We here propose that the increased activities of *n*SMase-2 and accelerated SM hydrolysis are also contributed to the pathogenesis of RA.

The present work further demonstrated that IDM administration could ameliorate the CFA-induced RA in rats. IDM is a common nonsteroidal anti-inflammatory drug that has been effectively used in the management of arthritis disease. Its mechanism of action is through inhibition of COX-2 activity to block the biosynthesis of PEG~2~ \[[@B19-molecules-23-01324]\]. As seen in [Figure 5](#molecules-23-01324-f005){ref-type="fig"}, the levels of specific SPL markers, including Cers and their metabolites, were significantly reversed by IDM treatment. These results indicate that IDM exerts anti-arthritic effects by down-regulating Cer synthesis, leading to the suppression of COX-2 activation and resulting PEG~2~ production in RA ([Figure 6](#molecules-23-01324-f006){ref-type="fig"}). In contrast, no significant intervention effects were observed for most SMs, suggesting that IDM has less impact on the *n*SMase-2-activated SM hydrolysis pathway. Our sphingolipidomic data, thus, affirm and extend previous research on the therapeutic actions of IDM.

3. Materials and Methods {#sec3-molecules-23-01324}
========================

3.1. Chemicals and Materials {#sec3dot1-molecules-23-01324}
----------------------------

The IS mixture (25 µmol/L for each SPLs in ethanol, catalog LM-6005) was purchased from Avanti Polar Lipids (Alabaster, AL, USA). It was composed of uncommon SPLs including So (d17:1), Sa (d17:0), S1P (d17:1), Cer (d18:1/12:0), C1P (d18:1/12:0), GlcCer (d18:1/12:0), and LacCer (d18:1/12:0), and SM (d18:1/12:0). Complete Freund's adjuvant (CFA), ammonium acetate (NH~4~Ac) and formic acid (HCOOH) were purchased from Sigma-Aldrich (St. Louis, MO, USA). LC-MS-grade methanol (MeOH), chloroform (CHCl~3~), and isopropanol (IPA) were purchased from Merck (Darmstadt, Germany). Ultrapure water (18.2 MΩ) was purified with a Milli-Q system (Millipore, Burlington, MA, USA). All other chemicals used were of analytical grade. Indomethacin (IDM) was obtained from Shanghai Shyndec Pharmaceutical Co., Ltd. (Shanghai, China).

3.2. Animal Experiment {#sec3dot2-molecules-23-01324}
----------------------

All experimental procedures were approved by the Ethics Committee of the Laboratory Animal Center of East China University of Science and Technology (project code: 20160917-2, approved date: 17 September, 2016). A total of 21 male SD rats (180 ± 10 g) were purchased from Shanghai SLAC Laboratory Animal Co., Ltd. (Shanghai, China). All animals were housed in an air-conditioned room at temperature of 25 ± 1 °C, relative humidity of 50 ± 10%, and 12 h dark/light cycle. The rats were fed with certified standard chow and tap water ad libitum. After one week of acclimation, rats were randomly divided into three groups as follows: the control, model, and IDM groups (*n* = 7 in each group). The model rats and IDM treated rats were injected intradermally with CFA (0.1 mL) for 20 days to induce arthritis. The control rats received an equal amount of physiological saline during the whole experiment. From days 11 to 20, the IDM group was injected intraperitoneally with IDM at a dose of 3 mg/kg body weight. At the end of the period, all animals were sacrificed and the sera were obtained for the following analysis.

3.3. Sample Pretreatment {#sec3dot3-molecules-23-01324}
------------------------

The extraction of rat serum SPLs was according to our established procedures with minor modifications \[[@B8-molecules-23-01324]\]. Briefly, 0.75 mL of MeOH:CHCl~3~ (2:1, *v*/*v*) and 10 µL of IS (each of 50 pmol amount) were added into 100 µL of rat serum. After sonication for 30 s, the mixture was incubated at 48 °C for 12 h. After cooling, 75 µL of KOH (1 mol/L in MeOH) was added and then incubated at 37 °C for 2 h. After cooling to room temperature, 3 µL of acetic acid was added to neutralize the mixture. The single-phase mixture was centrifuged and the supernatants were collected. The residue was re-extracted with 1 mL of MeOH:CHCl~3~ (1:2, *v*/*v*), centrifuged, and the supernatants were combined. The residue was dissolved in 0.4 mL of MeOH:CHCl~3~ (2:1, *v*/*v*) and 1 mL of CHCl~3~ and 2 mL of H~2~O was added followed by vortex mixing for 1 min. After centrifugation, the lower phase extract was collected and incorporated. The upper phase fraction was re-extracted with 1 mL of CHCl~3~, which was also combined with the extract. After extraction, the extract was evaporated to dryness under a gentle stream of nitrogen. The dried residue was reconstituted in 150 µL of MeOH, sonicated for 30 s, and filtered through a 0.22 µm syringe filter (Millipore, Burlington, MA, USA) into vials (Agilent, Santa Clara, CA, USA) for UPLC-MS analysis.

3.4. Chromatography and Mass Spectrometry {#sec3dot4-molecules-23-01324}
-----------------------------------------

An optimized UPLC-Q-TOF-MS condition established by our group was employed with several revisions \[[@B8-molecules-23-01324]\]. Briefly, chromatographic separation was performed on a Zorbax Eclipse Plus C18 column (100 × 2.1 mm, 1.8 µm, Agilent, Santa Clara, CA, USA) using an Agilent 1290 UPLC system (Santa Clara, CA, USA), equipped with a binary solvent delivery system and a high-performance auto-sampler. The mobile phase consisted of (A) MeOH:H~2~O:HCOOH (60:40:0.2, *v*/*v*/*v*) and (B) MeOH:IPA:HCOOH (10:90:0.2, *v*/*v*/*v*), both containing 10 mM NH~4~Ac. The gradient was as follows (flow rate of 0.35 mL/min): 0--3 min, 0% to 10% B; 3--5 min, 10% to 40% B; 5--5.3 min, 40% to 55% B; 5.3--8 min, 55% to 60% B; 8--8.5 min, 60% to 80% B; 8.5--10.5 min, 80% to 80% B; 10.5--16 min, 80% to 90% B; 16--19 min, 90% to 90% B; 19--22 min, 90% to 100% B; 22--26 min, 100% to 100% B. The column temperature was maintained at 40 °C and the injection volume was 2 µL.

Both qualitative and quantitative analysis was carried out using an Agilent 6530 Q-TOF mass spectrometer (Santa Clara, CA, USA), equipped with an electrospray ionization (ESI) source. The instrument was operated under 4 GHz mode to obtain high resolution data. ESI conditions were as follows: positive ion mode, capillary voltage 3500 V, nebulizer 35 psi, drying gas 10 L/min, gas temperature 350 °C, skimmer voltage 65 V, octopole RF voltage 750 V, fragmentor voltage 150 V. The collision energies (CEs) of targeted-MS/MS analysis were set at 10, 20, and 40 eV, respectively. Mass spectra were recorded over a range of *m*/*z* 50--1500. A reference solution was sprayed as continuous calibration using the following reference masses: *m*/*z* 121.0509 and 922.0098. All MS and MS/MS data was processed with MassHunter Workstation Software (version B.06.00, Agilent, Santa Clara, CA, USA).

3.5. Data Processing and Statistics {#sec3dot5-molecules-23-01324}
-----------------------------------

Agilent MassHunter Workstation software (version B.06.00) was employed for data processing. Identification of SPLs in rat serum were based on their accurate MS and MS/MS data. Relative quantification was carried out under MS mode and peak areas of the extracted ion chromatograms (EICs) for each SPL were integrated. The quantitative results were obtained by IS normalization and calculated as follows: Concentration of target SPL (µmol/L) = (Area of target SPL/Area of corresponding IS) × spiked concentration of IS. Eight IS corresponding to each subcategory are listed in [Table 1](#molecules-23-01324-t001){ref-type="table"}. All quantitative data were converted to Microsoft Excel format and imported into SIMCA-P+ 13.0 software (Umetrics, Umea, Sweden) for PLS-DA analysis. Statistical tests for identifying differentially expressed SPLs were performed with SPSS software (version 22.0, SPSS Inc., Chicago, IL, USA). Group variations were compared using one-way ANOVA analysis with a critical *p* value set to 0.05.

4. Conclusions {#sec4-molecules-23-01324}
==============

In summary, an UPLC-Q-TOF-MS-based sphingolipidomic approach was developed for the comprehensive identification and quantification of SPLs in rat serum. The benefits from the optimized LC-MS conditions, isomeric/isobaric interferences were reduced and a total of 120 SPLs covering seven subcategories were identified. The method was validated and demonstrated good reproducibility (overall RSDs ≤ 8.8%) and accuracy (overall recoveries ≥ 91.3%) with a wide linear range. This method was then applied to investigate the SPL alterations in RA rats and the intervention effects of IDM. PLS-DA analysis showed a clear separation of the model and control groups, while the IDM group exhibited a trend to recover to the controls. Twenty-six significantly changed SPL markers were explored, and levels of Cers and their metabolites were found to be reversed by IDM treatment. The therapeutic effects of IDM may be attributed to the inhibition of Cer-mediated COX-2 activation and resulting PEG~2~ liberation in RA. All of the above results show the promising potential of this method for understanding RA and the anti-arthritic mechanisms of relevant drugs.
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The following are available online, Figure S1. Characteristic MS/MS spectra of all identified SPLs by targeted-MS/MS analysis; Figure S2. Linear regression models constructed by plotting carbon number vs. retention time for SPLs; Figure S3. Intra- and inter-day RSDs of randomly selected SPLs in rat serum samples; Table S1. Linearity and sensitivity testing results of eight IS spiked in rat serum extracts; Table S2. Recovery testing results of eight IS spiked in rat serum extracts.
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![General structures, nomenclatures, and abbreviations for SPLs. *m*, carbon number of the sphingoid base backbone; *n*, carbon number of the fatty acid chain.](molecules-23-01324-g001){#molecules-23-01324-f001}

![Characteristic MS/MS spectra of (**a**) So (d18:1); (**b**) Cer (d18:0/20:0); (**c**) LacCer (d18:1/16:0); and (**d**) SM (d18:2/23:0) by Q-TOF-MS analysis. So, sphingosine; Cer, ceramide; LacCer, lactosylceramide; SM, sphingomyelin.](molecules-23-01324-g002){#molecules-23-01324-f002}

![(**a**) Differentiation of SPL isomers by targeted-MS/MS analysis. Two peaks in EIC of *m*/*z* 652.6602 showed characteristic fragment ion corresponding to Cer (d18:0/24:0) (*m*/*z* 266.2839) and Cer (d20:0/22:0) (*m*/*z* 294.3151); (**b**) Differentiation of \[M + H\]^+^ of SM (d18:2/24:2) and \[M + Na\]^+^ of SM (d18:1/22:0) that with the same exact *m*/*z*. The "real" \[M + H\]^+^ of SM (d18:2/24:2) was assigned by the observation of its corresponding \[M + Na\]^+^ ion. Cer, ceramide; SM, sphingomyelin.](molecules-23-01324-g003){#molecules-23-01324-f003}

![PLS-DA scores plot of rat serum data in control group (green triangles, *n* = 7), model group (red squares, *n* = 7), and IDM group (blue dots, *n* = 7).](molecules-23-01324-g004){#molecules-23-01324-f004}

![Altered levels of SPL markers in the control, model and IDM-treated rats. Data are represented as mean ± SD (*n* = 7 in each group). \*, Δ *p* \< 0.05 and \*\*, ΔΔ *p* \< 0.01 from one-way ANOVA analysis. The markers colored in red indicate their levels were significantly reversed by IDM treatment. Cer, Ceramide; So, sphingosine; Sa, sphinganine; S1P, sphingoid-1-phosphate; HexCer, hexosylceramide; SM, sphingomyelin.](molecules-23-01324-g005){#molecules-23-01324-f005}

![Proposed mechanistic pathways for the inflammation in RA and anti-arthritic effects of IDM. Upward and downward arrows represent up-regulation and down-regulation, respectively. Abbreviations: TNF-α, tumor necrosis factor-α; AA, arachidonic acid; PGE~2~, prostaglandin E~2~; COX-2, cyclooxygenase-2; SM, sphingomyelin; *n*SMase, neutralsphingomyelinase; Cer, ceramide; Sa&So, sphinganine and sphingosine; S1P, sphingosine-1-phosphate; HexCer, hexosylceramide.](molecules-23-01324-g006){#molecules-23-01324-f006}
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Identification of SPLs in rat serum by using UPLC-Q-TOF-MS.

  Class ^1^    No.        Name ^2^              Formula       RT (min)   \[M + H\]^+^ *m*/*z*   Score   MS/MS Fragments (*m*/*z*)
  ------------ ---------- --------------------- ------------- ---------- ---------------------- ------- ----------------------------------------------------------------------
  So&Sa        1          Sa (d14:0)            C14H31NO2     2.26       246.2422               99.89   228.2315, 210.2193, 198.2673
               2          So (d14:1)            C14H29NO2     2.60       244.2271               99.86   226.2156,208.1987, 196.2034
               3          So (t14:2)            C14H27NO3     4.45       258.2064               82.76   240.1939, 222.1958
               4          So (d15:1)            C15H31NO2     4.74       258.2428               99.74   240.2315, 222.2216, 210.2192
               5          Sa (d16:0)            C16H35NO2     5.08       274.2739               99.91   256.2627, 238.2575
               6          So (d16:1)            C16H33NO2     4.92       272.2584               86.47   254.2476, 236.2378
               7          Sa (t16:0)            C16H35NO3     5.12       290.2677               99.91   272.2571, 254.2487, 242.2472
               8          Sa (d18:0)            C18H39NO2     6.15       302.3053               98.75   284.2943, 266.2811
               9          So (d18:1)            C18H37NO2     9.85       300.2897               99.56   282.2796, 264.2728, 252.2642
               10         So (d18:2)            C18H35NO2     9.40       298.2745               85.01   280.2625, 262.2540
               11         Sa (d19:0)            C19H41NO2     11.91      316.3209               99.22   298.3109
               12         So (d19:1)            C19H39NO2     10.91      314.3041               99.31   296.2927
               13         Sa (d20:0)            C20H43NO2     13.84      330.3363               90.41   312.3268, 294.3189
               14         Sa (d24:0)            C24H51NO2     9.73       386.3950               99.34   368.3831, 350.3687
               \[IS-1\]   Sa (d17:0)            C17H37NO2     5.62       288.2872               \-      270.2790, 252.2685, 240.2682
               \[IS-2\]   So (d17:1)            C17H35NO2     7.41       286.2749               \-      268.2631, 250.2519, 238.2529
  S1P          15         S1P (d18:1)           C18H38NO5P    6.93       380.2561               99.89   282.2864, 264.2709
               \[IS-3\]   S1P (d17:1)           C11H36NO5P    7.89       366.2399               \-      348.2312, 268.2618, 250.2532
  Cer          16         Cer (d16:1/23:0)      C39H77NO3     17.11      608.5976               92.16   590.5851, 572.5759, 254.2505, 236.2367
               17         Cer (d17:1/24:1)      C41H79NO3     16.89      634.6133               85.39   616.6008, 598.5886, 268.2633, 250.2521
               18         Cer (d18:0/16:0)      C34H69NO3     14.03      540.5344               90.32   522.5218, 504.5128, 302.3115, 284.2943, 266.2829
               19         Cer (d18:0/20:0)      C38H77NO3     16.88      596.5967               94.77   578.5896, 560.5793, 284.2940, 266.2834
               20         Cer (d18:0/21:0)      C39H79NO3     17.70      610.6133               94.78   592.6011, 266.2884
               21         Cer (d18:0/22:0)      C40H81NO3     18.41      624.6289               99.59   606.6167, 588.6131, 302.3045, 284.2946, 266.2837
               22         Cer (d18:0/23:0)      C41H83NO3     19.36      638.6448               97.15   620.6309, 602.6203, 302.3067, 284.2946, 266.2843, 254.2850
               23         Cer (d18:0/24:0)      C42H85NO3     20.30      652.6596               98.57   634.6530, 616.6360, 302.3034, 284.2964, 266.2846, 254.2844
               24         Cer (d18:0/24:1)      C42H83NO3     18.61      650.6441               98.55   632.6337, 614.6224, 302.3030, 284.2950, 266.2840, 254.2840
               25         Cer (d18:0/26:1)      C44H87NO3     20.53      678.6751               84.92   660.6634, 284.2932, 266.2848
               26         Cer (d18:1/14:0)      C32H63NO3     12.00      510.4881               78.69   492.4790, 474.4692, 282.2814, 264.2651
               27         Cer (d18:1/16:0)      C34H67NO3     13.61      538.5191               99.81   520.5074, 502.4899, 282.2789, 264.2684, 252.2676
               28         Cer (d18:1/17:2)      C35H65NO3     16.61      548.5037               98.94   264.2651
               29         Cer (d18:1/17:3)      C35H63NO3     12.96      546.4881               96.54   282.2838, 264.2675
               30         Cer (d18:1/18:0)      C36H71NO3     14.96      566.5507               97.65   548.5396, 282.2766, 264.2681, 252.2659
               31         Cer (d18:1/20:0)      C38H75NO3     16.38      594.5820               89.81   576.5703, 558.5569, 546.5640, 282.2792, 264.2676, 252.2668
               32         Cer (d18:1/20:4)      C38H67NO3     13.98      586.5167               67.08   300.2854, 282.2756, 264.2686
               33         Cer (d18:1/21:0)      C39H77NO3     17.01      608.5976               95.73   282.2768, 264.2670, 252.2686
               34         Cer (d18:1/22:0)      C40H79NO3     17.81      622.6133               99.51   604.6030, 586.5865, 300.2959, 282.2779, 264.2684, 252.2680
               35         Cer (d18:1/23:0)      C41H81NO3     18.66      636.6285               99.56   618.6171, 600.6080, 282.2790, 264.2683, 252.2682
               36         Cer (d18:1/23:1)      C41H79NO3     17.11      634.6133               84.89   616.6008, 598.5886, 282.2802, 264.2681, 252.2660
               37         Cer (d18:1/24:0)      C42H83NO3     19.59      650.6441               99.24   632.6343, 614.6247, 602.6231, 282.2789, 264.2678, 252.2682
               38         Cer (d18:1/24:1)      C42H81NO3     18.31      648.6299               91.22   630.6188, 612.6087, 282.2789, 264.2682, 252.2684
               39         Cer (d18:1/25:0)      C43H85NO3     20.07      664.6588               92.95   646.6410, 628.6374, 300.2882, 282.2786, 264.2682, 252.2680
               40         Cer (d18:1/26:3)      C42H77NO3     17.81      644.5934               90.90   282.2805, 264.2683
               41         Cer (d18:2/16:0)      C34H65NO3     12.71      536.5037               70.02   518.4939, 500.4770, 280.2648, 262.2522, 250.2529
               42         Cer (d18:2/18:2)      C36H65NO3     13.63      560.4967               90.73   542.4881, 280.2661, 262.2545
               43         Cer (d18:2/22:0)      C40H77NO3     16.79      620.5976               98.38   602.5861, 584.5741, 298.2758, 280.2635, 262.2526, 250.2515
               44         Cer (d20:0/16:0)      C36H73NO3     12.67      568.5663               97.20   312.3264, 294.3158
               45         Cer (d20:0/22:0)      C42H85NO3     20.91      652.6602               99.80   634.6507, 616.6358, 312.3241, 294.3116
               46         Cer (t18:0/16:0)      C34H69NO4     12.91      556.5299               81.00   502.4892, 300.2886, 282.2773, 264.2704
               47         Cer (t18:0/19:2)      C37H71NO5     15.96      610.5405               99.43   282.2797, 264.2680
               \[IS-4\]   Cer (d18:1/12:0)      C30H59NO3     10.38      482.4564               \-      464.4507, 282.2779, 264.2682, 252.2670
  C1P          48         C1P (d18:0/16:0)      C34H70NO6P    12.21      620.5014               97.60   266.2896
               49         C1P (d18:1/12:3)      C30H54NO6P    9.17       556.3733               90.34   264.2703
               50         C1P (d18:1/16:0)      C34H68NO6P    11.41      618.4866               97.06   264.2682
               51         C1P (d18:1/16:2)      C34H64NO6P    11.09      614.4544               91.65   264.2693
               52         C1P (d18:1/18:0)      C36H72NO6P    14.84      646.5187               76.43   282.2779, 264.2691
               53         C1P (d18:1/26:0)      C44H88NO6P    25.49      758.6422               86.48   264.2698
               54         C1P (d18:2/14:1)      C32H60NO6P    9.67       586.4231               96.64   262.2576
               \[IS-5\]   C1P (d18:1/12:0)      C30H60NO6P    9.61       562.4226               \-      544.4109, 464.4442, 446.4342, 282.2719, 264.2677
  HexCer ^3^   55         HexCer (d18:0/20:0)   C44H87NO8     13.19      758.6504               99.76   596.5976, 578.5845, 284.2936, 266.2851
               56         HexCer (d18:1/16:0)   C40H77NO8     11.65      700.5722               90.23   520.4977, 502.4891, 282.2819, 264.2683, 252.2643
               57         HexCer (d18:1/20:0)   C44H85NO8     14.31      756.6328               98.50   738.6248, 576.5731, 282.2748, 264.2694, 252.2673
               58         HexCer (d18:1/22:0)   C46H89NO8     15.95      784.6661               98.10   766.6539, 622.6147, 604.6016, 586.5895, 282.2804, 264.2681, 252.2644
               59         HexCer (d18:1/23:0)   C47H91NO8     16.60      798.6817               93.90   780.6693, 618.6176, 600.6079, 282.2786, 264.2683, 252.2675
               60         HexCer (d18:1/24:0)   C48H93NO8     17.27      812.6972               90.51   794.6858, 632.6339, 614.6225, 282.2791, 264.2683, 252.2681
               61         HexCer (d18:1/24:1)   C48H91NO8     16.05      810.6786               87.89   630.6161, 612.6090, 282.2784, 264.2686, 252.2670
               \[IS-6\]   HexCer (d18:1/12:0)   C36H69NO8     9.98       644.5093               \-      626.4985, 464.4457, 446.4346, 282.2790, 264.2683, 252.2684
  LacCer       62         LacCer (d18:0/22:0)   C52H101NO13   14.39      948.7346               98.47   624.6283, 606.6159, 284.2937, 266.2884
               63         LacCer (d18:1/16:0)   C46H87NO13    12.02      862.6245               99.73   844.6111, 538.5173, 520.5067, 282.2785, 264.2679, 252.2678
               64         LacCer (d18:1/22:0)   C52H99NO13    15.73      946.7177               92.24   928.7105, 928.7105, 604.6023, 586.5924, 282.2796, 264.2682, 252.2669
               65         LacCer (d18:1/24:0)   C54H103NO13   15.14      974.7502               99.16   956.7359, 794.6845, 632.6315, 614.6225, 282.2775, 264.2675, 252.2685
               66         LacCer (d18:1/24:1)   C54H101NO13   15.86      972.7346               98.93   954.7245, 792.6653, 630.6171, 612.6074, 282.2782, 264.2680, 252.2672
               \[IS-7\]   LacCer (d18:1/12:0)   C42H79NO13    9.78       806.5621               \-      788.5510, 626.5002, 464.4464, 446.4358, 264.2686
  SM           67         SM (d16:1/14:0)       C35H71N2O6P   11.53      647.5109               98.44   236.2362, 184.0737
               68         SM (d17:0/18:0)       C40H83N2O6P   15.14      719.6062               96.03   252.2691, 184.0731
               69         SM (d18:0/14:0)       C37H77N2O6P   13.10      677.5592               98.82   266.2830, 184.0729
               70         SM (d18:0/16:0)       C39H81N2O6P   14.43      705.5905               98.83   266.2810, 184.0727
               71         SM (d18:0/18:0)       C41H85N2O6P   15.85      733.6218               95.37   266.2899, 184.0736
               72         SM (d18:0/20:0)       C43H89N2O6P   17.30      761.6531               95.46   266.2787,184.0725
               73         SM (d18:0/22:0)       C45H93N2O6P   18.87      789.6844               99.17   266.2881, 184.0725
               74         SM (d18:0/24:0)       C47H97N2O6P   20.75      817.7157               99.36   266.2808, 184.0724
               75         SM (d18:1/14:0)       C37H75N2O6P   12.59      675.5436               99.00   264.2671, 184.0729
               76         SM (d18:1/16:0)       C39H79N2O6P   13.82      703.5755               99.19   264.2661, 184.0728
               77         SM (d18:1/16:3)       C39H73N2O6P   12.59      697.5279               97.13   264.2659, 184.0728
               78         SM (d18:1/17:0)       C40H81N2O6P   14.53      717.5904               98.69   264.2618, 184.0728
               79         SM (d18:1/18:0)       C41H83N2O6P   15.24      731.6062               98.06   264.2685, 184.0729
               80         SM (d18:1/18:1)       C41H81N2O6P   14.21      729.5926               86.17   264.2614, 184.0726
               81         SM (d18:1/18:2)       C41H79N2O6P   14.41      727.5737               99.30   264.2659, 184.0727
               82         SM (d18:1/18:3)       C41H77N2O6P   13.82      725.5569               94.58   264.2608, 184.0725
               83         SM (d18:1/19:0)       C42H85N2O6P   15.98      745.6218               99.44   264.2675, 184.0729
               84         SM (d18:1/19:1)       C42H83N2O6P   14.92      743.6064               97.01   264.2699, 184.0730
               85         SM (d18:1/20:0)       C43H87N2O6P   16.69      759.6361               91.31   264.2691, 184.0729
               86         SM (d18:1/20:1)       C43H85N2O6P   15.65      757.6218               99.58   264.2687, 184.0725
               87         SM (d18:1/20:2)       C43H83N2O6P   14.52      755.6062               98.54   264.2703, 184.0733
               88         SM (d18:1/20:3)       C43H81N2O6P   15.24      753.5905               91.53   264.2691, 184.0728
               89         SM (d18:1/21:0)       C44H89N2O6P   17.45      773.6531               99.62   264.2663, 184.0731
               90         SM (d18:1/21:1)       C44H87N2O6P   16.18      771.6367               98.99   264.2676, 184.0729
               91         SM (d18:1/22:0)       C45H91N2O6P   18.20      787.6682               89.66   264.2738, 184.0729
               92         SM (d18:1/22:1)       C45H89N2O6P   17.10      785.6521               90.18   264.2700, 184.0729
               93         SM (d18:1/22:2)       C45H87N2O6P   15.85      783.6374               98.59   264.2717, 184.0728
               94         SM (d18:1/22:3)       C45H85N2O6P   16.71      781.6218               94.77   264.2674, 184.0723
               95         SM (d18:1/23:0)       C46H93N2O6P   19.02      801.6844               99.32   264.2665, 184.0725
               96         SM (d18:1/23:2)       C46H89N2O6P   16.57      797.6506               92.95   264.2660, 184.0730
               97         SM (d18:1/23:3)       C46H87N2O6P   17.45      795.6354               81.68   264.2723, 184.0732
               98         SM (d18:1/24:0)       C47H95N2O6P   19.98      815.7001               97.84   264.2705, 184.0724
               99         SM (d18:1/24:1)       C47H93N2O6P   18.28      813.6844               98.88   264.2691, 184.0728
               100        SM (d18:1/24:4)       C47H87N2O6P   15.44      807.6375               97.83   264.2698, 184.0731
               101        SM (d18:1/25:0)       C48H97N2O6P   20.79      829.7155               99.43   264.2667, 184.0732
               102        SM (d18:1/25:1)       C48H95N2O6P   19.24      827.7001               95.78   264.2600, 184.0728
               103        SM (d18:1/25:3)       C48H91N2O6P   19.02      823.6665               96.01   264.2643, 184.0731
               104        SM (d18:1/25:4)       C48H89N2O6P   17.85      821.6506               88.64   264.2666, 184.0719
               105        SM (d18:1/26:1)       C49H97N2O6P   20.21      841.7157               99.25   264.2691, 184.0725
               106        SM (d18:1/26:2)       C49H95N2O6P   18.81      839.7001               99.73   264.2754, 184.0730
               107        SM (d18:1/26:3)       C49H93N2O6P   19.98      837.6800               95.27   264.2679, 184.0730
               108        SM (d18:1/26:4)       C49H91N2O6P   18.28      835.6683               94.37   264.2731, 184.0735
               109        SM (d18:2/18:1)       C41H79N2O6P   14.41      727.5749               98.92   262.2556, 184.0727
               110        SM (d18:2/18:3)       C41H75N2O6P   12.90      723.5436               90.63   262.2628, 184.0733
               111        SM (d18:2/20:0)       C43H85N2O6P   15.48      757.6211               92.69   262.2501, 184.0730
               112        SM (d18:2/20:2)       C43H81N2O6P   15.24      753.5905               91.53   262.2516, 184.0708
               113        SM (d18:2/20:3)       C43H79N2O6P   14.21      751.5749               86.38   262.2509, 184.0731
               114        SM (d18:2/21:0)       C44H87N2O6P   16.40      771.6353               98.99   262.2554, 184.0731
               115        SM (d18:2/23:0)       C46H91N2O6P   17.84      799.6679               98.81   781.6544, 262.2526, 184.0726
               116        SM (d18:2/24:0)       C47H93N2O6P   18.28      813.6842               98.28   262.2562, 184.0728
               117        SM (d18:2/24:2)       C47H89N2O6P   16.30      809.6533               98.67   262.2502, 184.0728
               118        SM (d20:0/24:4)       C49H93N2O6P   19.98      837.6844               87.77   294.3110, 184.0738
               119        SM (d20:1/23:4)       C48H89N2O6P   17.85      821.6531               93.97   292.3001, 184.0730
               120        SM (t18:0/16:1)       C39H79N2O7P   13.32      719.5698               96.54   300.2822, 264.2643, 184.0729
               \[IS-8\]   SM (d18:1/12:0)       C35H71N2O6P   9.94       647.5116               \-      282.2776, 264.2681, 252.2660, 184.0731

^1^ IS, internal standard; So, sphingosine; Sa, sphinganine; S1P, sphingosine-1-phosphate; Cer, ceramide; C1P, ceramide-1-phosphate; HexCer, hexosylceramide; LacCer, lactosylceramide; SM, sphingomyelin. ^2^ Annotation of the sphingoid backbone denotes the number of hydroxyl groups, the number of carbon atoms, and the number of the unsaturation degree (e.g., d means two hydroxyl groups; t means three hydroxyl groups (i.e., phyto-)); annotation of the fatty acid chain indicates the number of carbon atoms and the number of unsaturation degree. ^3^ HexCer includes glucosylceramide (GlcCer) and galactosylceramide (GalCer), which cannot be distinguished by this method.
